Evolus, Inc. (EOLS) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evolus, Inc. Common Stock.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.132 Good afternoon, everyone, and thank you for standing by. 00:00:03.132 -- 00:00:07.372 Welcome to Evalyst's second quarter 2026 earnings call. 00:00:07.372 -- 00:00:11.713 If anyone should require operator assistance during the conference, please press star 00:00:11.713 -- 00:00:16.874 zero on your telephone keypad. As a reminder, today's conference call is being 00:00:16.874 -- 00:00:22.275 recorded and webcast live. All participants are in a listen-only mode. 00:00:22.275 -- 00:00:26.135 After the speaker's remarks, there will be a question and answer session. 00:00:26.135 -- 00:00:31.210 I would now like to turn the conference over to Nareg Sagherian, Vice President 00:00:31.210 -- 00:00:35.271 and Head of Global Vestor Relations in Corporate Communications. 00:00:35.271 -- 00:00:37.711 Please go ahead. 00:00:38.011 -- 00:00:42.393 Thank you, Operator, and welcome to everyone joining us on today's call to review Evelus' 00:00:42.393 -- 00:00:47.434 second quarter financial results. Our second quarter press release is now available on 00:00:47.434 -- 00:00:51.745 the Investor Relations section of our website at evelus.com. 00:00:51.745 -- 00:00:56.608 Joining me on today's call are David Moatazedi, President and Chief Executive Officer, 00:00:56.608 -- 00:01:01.912 Rui Avelar, Chief Medical Officer and Head of R&D, and Tatjana Mitchell, Chief Financial 00:01:01.912 -- 00:01:05.855 Officer. Today's call will include forward-looking statements. 00:01:05.855 -- 00:01:10.298 Actual results may differ materially due to risks and uncertainties outlined in our earnings 00:01:10.298 -- 00:01:12.880 press release and SEC filings. 00:01:12.880 -- 00:01:16.662 These forward-looking statements are based on current assumptions, and we undertak...